This application from the Center for Cell and Gene Therapy (CAGT) / Baylor College of Medicine (BCM) describes a comprehensive training program in cellular and genetic therapies, for both graduate students and postdoctoral fellows. This burgeoning area of translational research remains deficient in comprehensive training schemes for individuals who wish to address basic and clinical translational aspects using these biological agents. A stimulating program of education and laboratory training from high quality mentors should continue to attract promising candidates, including under-represented minorities, to this emerging field and increase the likelihood that they will pursue careers as translational researchers. Translation of basic research discoveries to clinical practice has become increasingly complex, such that advances in basic research can only be efficiently implemented when teams of investigators collaborate to validate these novel strategies in the clinic. This type of translational research training requires the involvement of a dedicated team of mentors with diverse but complementary skills. The proposed training exploits the outstanding biomedical curricula and experienced faculty within BCM and CAGT. A cadre of 26 faculty members with research interests that include vector design and targeting, stem cell biology, molecular and cellular genetics, immunotherapy, gene therapy and stem cell transplantation will be available to mentor graduate students and both MD and PhD postdoctoral fellows. Major strengths of the program are its;(1) targeting of rigorous basic biomedical science and clinical research training toward a translational goal;(2) established and multilevel integration with the proven scientific excellence of cell biology and genetics research training programs at BCM;(3) involvement of mentors, including program director and co directors, who have a wealth of experience in translational research and in training young investigators (4) availability of unique resources such as the GMP laboratories for training. Augmenting the formal course work and laboratory training will be opportunities to present recent research findings at annual retreats sponsored by CAGT and academic departments within BCM. During the first 8 years of funding this approach has successfully trained 14 graduate students who have completed their PhD degrees: all remain in academic medicine. Eight postdoctoral fellows have completed training in translational cell and gene therapy research and all remain in the field with 5 appointed to academic faculty positions and 3 in biotechnology. Of all trainees who have completed training or who are still in training 9 are under- represented minorities and 3 have under-privileged backgrounds. The maintenance of support will allow us to continue to provide trainees with a strong foundation for translational research careers in this emerging area.

Public Health Relevance

This proposal aims to train young researchers so that they can move cell and gene based therapies from basic science laboratories and into the clinic. These therapies hold great promise for regenerative medicine, cancer and other disorders, but can only be implemented after the specialized training that this award will provide

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL092332-12
Application #
8627194
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Welniak, Lisbeth A
Project Start
2003-07-01
Project End
2018-06-30
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
12
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Pediatrics
Type
Schools of Medicine
DUNS #
City
Houston
State
TX
Country
United States
Zip Code
77030
Scavuzzo, Marissa A; Yang, Diane; Borowiak, Malgorzata (2017) Organotypic pancreatoids with native mesenchyme develop Insulin producing endocrine cells. Sci Rep 7:10810
Barzi, Mercedes; Pankowicz, Francis P; Zorman, Barry et al. (2017) A novel humanized mouse lacking murine P450 oxidoreductase for studying human drug metabolism. Nat Commun 8:39
Rouce, Rayne H; Sharma, Sandhya; Huynh, Mai et al. (2017) Recent advances in T-cell immunotherapy for haematological malignancies. Br J Haematol 176:688-704
Shum, Thomas; Omer, Bilal; Tashiro, Haruko et al. (2017) Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells. Cancer Discov 7:1238-1247
Tashiro, Haruko; Sauer, Tim; Shum, Thomas et al. (2017) Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1. Mol Ther 25:2202-2213
Mata, Melinda; Gerken, Claudia; Nguyen, Phuong et al. (2017) Inducible Activation of MyD88 and CD40 in CAR T Cells Results in Controllable and Potent Antitumor Activity in Preclinical Solid Tumor Models. Cancer Discov 7:1306-1319
Ku, Amy T; Shaver, Timothy M; Rao, Ajay S et al. (2017) TCF7L1 promotes skin tumorigenesis independently of ?-catenin through induction of LCN2. Elife 6:
Tanoue, Kiyonori; Rosewell Shaw, Amanda; Watanabe, Norihiro et al. (2017) Armed Oncolytic Adenovirus-Expressing PD-L1 Mini-Body Enhances Antitumor Effects of Chimeric Antigen Receptor T Cells in Solid Tumors. Cancer Res 77:2040-2051
John Lin, Chia-Ching; Yu, Kwanha; Hatcher, Asante et al. (2017) Identification of diverse astrocyte populations and their malignant analogs. Nat Neurosci 20:396-405
Kruse, Robert L; Shum, Thomas; Legras, Xavier et al. (2017) In Situ Liver Expression of HBsAg/CD3-Bispecific Antibodies for HBV Immunotherapy. Mol Ther Methods Clin Dev 7:32-41

Showing the most recent 10 out of 125 publications